Literature DB >> 14578245

Archimedes: a trial-validated model of diabetes.

David M Eddy1, Leonard Schlessinger.   

Abstract

OBJECTIVE: To build a mathematical model of the anatomy, pathophysiology, tests, treatments, and outcomes pertaining to diabetes that could be applied to a wide variety of clinical and administrative problems and that could be validated. RESEARCH DESIGN AND METHODS: We used an object-oriented approach, differential equations, and a construct we call "features." The level of detail and realism was determined by what clinicians considered important, by the need to distinguish clinically relevant variables, and by the level of detail used in the conduct of clinical trials.
RESULTS: The model includes the pertinent organ systems, more than 50 continuously interacting biological variables, and the major symptoms, tests, treatments, and outcomes. The level of detail corresponds to that found in general medical textbooks, patient charts, clinical practice guidelines, and designs of clinical trials. The model is continuous in time and represents biological variables continuously. As demonstrated in a companion article, the equations can simulate a variety of clinical trials and reproduce their results with good accuracy.
CONCLUSIONS: It is possible to build a mathematical model that replicates the pathophysiology of diabetes at a high level of biological and clinical detail and that can be tested by simulating clinical trials.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578245     DOI: 10.2337/diacare.26.11.3093

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  63 in total

1.  Guidelines: we'll always need them, we sometimes dislike them, and we have to make them better.

Authors:  R Kahn
Journal:  Diabetologia       Date:  2010-08-25       Impact factor: 10.122

2.  Impact of blood glucose self-monitoring errors on glucose variability, risk for hypoglycemia, and average glucose control in type 1 diabetes: an in silico study.

Authors:  Marc D Breton; Boris P Kovatchev
Journal:  J Diabetes Sci Technol       Date:  2010-05-01

Review 3.  A Comprehensive Review of Novel Drug-Disease Models in Diabetes Drug Development.

Authors:  Puneet Gaitonde; Parag Garhyan; Catharina Link; Jenny Y Chien; Mirjam N Trame; Stephan Schmidt
Journal:  Clin Pharmacokinet       Date:  2016-07       Impact factor: 6.447

4.  Using mechanistic models to simulate comparative effectiveness trials of therapy and to estimate long-term outcomes in HIV care.

Authors:  Mark S Roberts; Kimberly A Nucifora; R Scott Braithwaite
Journal:  Med Care       Date:  2010-06       Impact factor: 2.983

5.  Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.

Authors:  Wen Wan; M Reza Skandari; Alexa Minc; Aviva G Nathan; Parmida Zarei; Aaron N Winn; Michael O'Grady; Elbert S Huang
Journal:  Med Decis Making       Date:  2018-11       Impact factor: 2.583

6.  Requisite models for strategic commissioning: the example of type 1 diabetes.

Authors:  Mara Airoldi; Gwyn Bevan; Alec Morton; Mónica Oliveira; Jenifer Smith
Journal:  Health Care Manag Sci       Date:  2008-06

7.  Computational reasoning across multiple models.

Authors:  Guy Tsafnat; Enrico W Coiera
Journal:  J Am Med Inform Assoc       Date:  2009-08-28       Impact factor: 4.497

Review 8.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

9.  Validating a dimensionless number for glucose homeostasis in humans.

Authors:  David J Klinke
Journal:  Ann Biomed Eng       Date:  2009-06-10       Impact factor: 3.934

10.  In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes.

Authors:  Boris P Kovatchev; Marc Breton; Chiara Dalla Man; Claudio Cobelli
Journal:  J Diabetes Sci Technol       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.